Resources

383 Resources for

the pharma industry

  • Subscribe to this listing via:
  • RSS
  • Email
The Incredible Shrinking Pharma Industry
It's not just layoffs anymore. The market-research firm Industrial Info Resources notes in a recent report that pharma plans to shutter 26 plants and research facilities across North America, in addition to the tens of thousands of sales reps, scientists and manufacturing-plant workers big drugmakers are letting go. Those closures...
Tags: Blockbuster, David P. Hamilton, Marketing, Pharmaceutical Company
Blog posts 2008-07-27
Research and Markets: Pfizer's Recent Implosion speaks to the Heart of the Challenges Facing the Pharmaceutical Industry Today
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c53634) has announced the addition of new Decision Resources report Executing Change in the Pharma Industry--Prescription for Pfizer to their offering.
Tags: Pfizer Inc.
Research articles 2007-04-11
Pharma's Future: Back to Basics
With declining R & D production, reduced effectiveness of the blockbuster model seven new drug discovery technologies, its clear the pharma industry needs to change. According to the futurologists, several changes will take place and a new pharma model will be adopted. Based on a recent survey of major industry...
Tags: Pharmaceutical Company, PricewaterhouseCoopers LLP
White papers 2004-06-01
Pharma Forums Have Special Needs, Too
Pharma Forums Have Special Needs, TooA bit cynical?I have a slightly diiferent view on this. First, it seems entirely reasonable that a conference facility would train it's employees to address the needs of their guests, whomever they are.As for the comment on training staff as to what can be...
Tags: business meeting, pharmaceutical company, Special Needs
Discussion threads 2008-06-04
MGI PHARMA to Present at the BioCentury NewsMakers in the Biotech Industry Conference
MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced that it will present at the BioCentury NewsMakers in the Biotech Industry Investment Conference on Friday, September 9, at 2:20 p.m. Eastern Time. Lonnie Moulder, president and chief executive officer of MGI PHARMA, will give the presentation, which will be webcast live...
Tags: Biocentury
Research articles 2005-09-02
MGI PHARMA To Present at the BioCentury NewsMakers in the Biotech Industry Conference
MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced that it will present at the BioCentury NewsMakers in the Biotech Industry Conference on September 9, 2004 at 1:30 p.m. Eastern Time. Lonnie Moulder, president and chief executive officer of MGI PHARMA, will give the presentation, which will be webcast live over...
Tags: Biocentury
Research articles 2004-09-02
Democrats Accuse Pharma Industry Of Gutting Drug Reimportation Bill.(Brief Article)
DEMOCRATS COMPLAIN that an agreement reached between House and Senate negotiators to allow US-made prescription drugs to be reimported from foreign countries where they are usually sold at much lower prices has been effectively gutted by the pharma DEMOCRATS COMPLAIN that an agreement reached...
Tags: FDA, pharmaceutical company, PhRMA
Research articles 2000-10-16
Global pressures force Pharma Industry to re-think role of IT solutions and which to prioritise.
M2 PRESSWIRE-5 June 2007-DATAMONITOR: Global pressures force Pharma Industry to re-think role of IT solutions and which to prioritiseC1994-2007 M2 COMMUNICATIONS LTD RDATE:07062007 London - A new report by independent market analysis firm Datamonitor (DTM.L), highlights three key trends that will...
Tags: IT Solutions Inc.
Research articles 2007-06-05
Zacks.com Features the Following Top Stocks in the Drugs Industry: Angiotech Pharma, Cubist Pharma, ImmunoGen, Johnson & Johnson, and QLT
CHICAGO -- The Vioxx withdrawal may have sent a shiver through the drugs industry, but the All Stars can keep you from catching cold in this innovative space. Read about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI), Cubist Pharmaceuticals, Inc. (NASDAQ:CBST), ImmunoGen, Inc. (NASDAQ:IMGN), Johnson & Johnson (NYSE:JNJ) and QLT, Inc. (NASDAQ:QLTI). Discover...
Tags: Johnson & Johnson, stock
Research articles 2004-11-22
HCL introduces Equipment Log Manager for the pharmaceutical industry; Compliance needs driving new technology opportunities in the pharma market.
M2 PRESSWIRE-5 September 2006-HCL Technologies: HCL introduces Equipment Log Manager for the pharmaceutical industry; Compliance needs driving new technology opportunities in the pharma marketC1994-2006 M2 COMMUNICATIONS LTD RDATE:05092006 London, UK: HCL Technologies Ltd. HCL, one of India's leading global IT...
Tags: IT Solutions Inc.
Research articles 2006-09-05
Pharma industry pushing for senior drug benefits. (Markets: Washington).(industry also wants to reduce time it takes to review drugs)(Brief Article)
THE PHARMACEUTICALS industry plans to step up its campaign to win congressional approval of a prescription drug benefit for the nation's senior citizens, a top industry official said last week. "As we continue to bring newer and better me ...
Tags: FDA, patient, benefit
Research articles 2002-02-04
Pharma Industry Concerned Over Drug Competition Bill.(Brief Article)
THE PHARMACEUTICAL industry is concerned over a Senate committee's approval of legislation that would require brand-name drug companies to report to federal officials any time they pay a generic manufacturer to delay market introduction of a lower- THE PHARMACEUTICAL industry is concerned over a...
Tags: drug company, U.S. Senate, pharmaceutical company
Research articles 2001-10-29
The Healthcare Industry Makes Its Move on Reform
The Obama Administration’s reaction to the healthcare industry’s offer to cut $2 trillion in costs over the next decade was predictably favorable. Administration officials said that if the industry could fulfill its commitment, it would cut the average annual cost of coverage for a family of four by $2,500 in...
Tags: Barack Obama, Benefits, Health Care, Healthcare, Healthcare Reform, Human Resources, Ken Terry, Management, Obama Administration, Strategy, Vertical Industries
Blog posts 2009-05-11
Would complete disclosure cure the NDA-rejection rash?
John Jenkins, the head of the FDA's Office of New Drugs, has the perfect cure for a chronic rash of poorly conceived new drug applications: Sunshine. And plenty of it, according to a piece in The RPM Report . Jenkins suggests that the agency's complete response letters should...
Tags: application, Microsoft Office, FDA, response letter
News items 2009-12-10
Former FDA, CVS RFID Visionaries Join SupplyScape Board of Advisors; Bill Hubbard, Paul Rudolf and Jack DeAlmo Bring Vital Industry Perspective to Drug Supply Chain Security Leader
WOBURN, Mass. -- When the Pharma industry considers adopting Radio Frequency Identification RFID to help solve the problems of drug counterfeiting and diversion, key individuals who set the government and industry agendas come to mind. Bill Hubbard, former FDA senior associate commissioner, was often called to Capitol Hill to educate...
Tags: RFID, FDA, CVS Corp., advisor, leader
Research articles 2006-06-07
Senior prescription drug benefit remains pharma industry's top priority on Capitol Hill. (News).
ENACTING A Medicare prescription drug benefit for the nation's senior citizens will remain the pharmaceutical industry's top policy priority on Capitol Hill this year. "We hope that the new Congress will get the message that seniors need ENACTING...
Tags: Medicare, pharmaceutical company, U.S. Congress
Research articles 2003-01-06
Life Science Insights to Present ''The Rise of The Pharma CIO'' at IDC's Annual Directions Conferences
FRAMINGHAM, Mass. -- Fundamental shifts in the pharmaceutical industry are driving key changes in the industry's business processes and IT strategies. IT decision making is moving to center stage to help reduce costs and address compliance imperatives, and, as a result, CIOs are taking a larger role in the corporate...
Tags: International Data Corp., life science
Research articles 2005-03-08
Acceleron to Present at the BioCentury Future Leaders in the Biotech Industry Conference
CAMBRIDGE, Mass. -- Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including bone, muscle and red blood cells, today announced...
Tags: Biocentury
Research articles 2009-03-26
The Next Generation IT Infrastructure for Global Pharmaceutical Companies
This paper looks at the next generation IT infrastructure for global pharmaceutical companies; outsourcing in the pharma industry; and what's important for ambitious companies when it comes to global supply chains; plus, a feature on the main problems of research. It also looks at activities that companies can address today...
Tags: IT Infrastructure, Capgemini, Information Technology, Pharmaceutical Company
White papers 2004-04-06
Generic Drugs: Industry Snapshot
Mike Havrilla submits:Global Generic Drug Industry: Benchmark Comps  Global Generic Drug Industry: Top 5 Companies by Market Cap Global Generic Drugs: Top 5 Companies by Stock Performance  The accompanying tables provide a snapshot of my 38-company Global Generic Drug Index, which is rapidly consolidating amidst a flurry of recent M&A activity --...
Tags: Healthcare, Bentley Pharmaceuticals Inc., Barr Pharmaceuticals Inc., Momenta Pharmaceuticals Inc., Sanofi-Aventis
External links 2008-08-15
advertisement
advertisement
Click Here